The 262T>C promoter polymorphism of the catalase gene is associated with diabetic neuropathy in type 1 diabetic Russian patients

Diabetes and Metabolism

Volumn 32, Issue 1, 2006, Pages 63-68

  Chistiakov, D A ^a   Zotova, E V ^b   Savost'anov, K V ^c   Bursa, T R ^d   Galeev, I V ^d   Strokov, I A ^d   Nosikov, V V ^c  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c STATE RESEARCH INSTITUTE OF GENETICS AND SELECTION OF INDUSTRIAL MICROORGANISMS   (Russian Federation)

^d I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Catalase promoter polymorphism; Diabetic neuropathy; Oxidative stress; Type 1 diabetes

Indexed keywords

CATALASE; CYSTEINE; ERYTHROCYTE ENZYME; GENOMIC DNA; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; HEMOGLOBIN; LEUCINE; PROLINE; THREONINE; CYTOSINE; DNA; THYMINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; HEMOGLOBIN DETERMINATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; BLOOD; ENZYMOLOGY; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; REFERENCE VALUE; RUSSIAN FEDERATION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CATALASE; CYTOSINE; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; DNA; FEMALE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); REFERENCE VALUES; RUSSIA; THYMINE;

EID: 33646083956     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70248-3     Document Type: Article

References (21)

1. Obrosova IG. Update on the pathogenesis of diabetic neuropathy. Curr Diab Rep 2003;3:439-45
2. Hermenegildo C, Raya A, Roma J, Romero FJ. Decreased gluthatione peroxidase activity in sciatic nerve of alloxan-induced diabetic mice and its correlation with blood glucose levels. Neurochem Res 1993;18:893-96
3. Van Dam PS, van Asbeck BS, Bravenboer B, van Oirschot JFLM, Gispen WH, Marx JJM. Nerve function and oxidative stress in diabetic and vitamin E-deficient rats. Free Radic Biol Med 1998;24:18-26
4. Martin-Gallan P, Carrascosa A, Gussinye M, Dominguez C. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic Biol Med 2003;34:1563-74
5. Merzouk S, Hichami A, Madani S, et al. Antioxidant status and levels of different vitamins determined by high performance liquid chromatography in diabetic subjects with multiple complications. Gen Physiol Biophys 2003;22:15-27
6. Yan H, Harding JJ. Glycation-induced inactivation and loss of antigenicity of catalase and superoxide dismutase. Biochem J 1997; 328:599-605
7. Morgan PE, Dean RT, Davies MJ. Inactivation of cellular enzymes by carbonyls and protein-bound glycation/glycoxidation products. Arch Biochem Biophys 2002;403:259-69
8. Strokov IA, Bursa TR, Drepa OI, Zotova EV, Nosikov VV, Ametov AS. Predisposing genetic factors for diabetic polyneuropathy in patients with type 1 diabetes: a population-based case-control study. Acta Diabetol 2003;40(suppl 1):S375-S279
9. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
10. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26(suppl 1):S5-S20
11. Consensus Statement. Report and recommendations of the San Antonio on diabetic neuropathy. American Diabetes Association American Academy of Neurology. Diabetes Care 1988;11:592-7
12. Bentler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963;61:882-8
13. Bentler E, ed. Red cell metabolism. A manual of biochemical methods. New York: Grune & Stratton, 1975
14. Folsberg E, de Faire U, Morgenstern R. Low yield of polymorphisms from EST Blast searching: analysis of genes related to oxidative stress and verification of the P197L polymorphism in GPX1. Hum Mutat 1999;13:294-300
15. Folsberg L, Lyrenas L, de Faire U, Morgenstern R. A common functional C-T substitution polymorphisms in the promoter region of the human catalase gene influences transcrition factor binding, reported gene transcription and is correlated to blood catalase levels. Free Radic Biol Med 2001;30:500-5
16. Chen C-L, Liu Q, Relling MV. Simultaneous characterization of glutathione-S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. Pharmacogenomics 1996;6:187-91
17. Thornalley PJ, McLellan AC, Lo TW, Benn J, Sonksen PH. Negative association between erythrocyte reduced glutathione concentration and diabetic complications. Clin Sci 1996;91:575-82
18. Iwata-Ichikawa E, Kondo Y, Miyazaki I, Asanuma M, Ogawa N. Glial cells protect neurons against oxidative stress via transcriptional up-regulation of the glutathione synthesis. J Neurochem 1999;72:2234-44
19. Dickinson PJ, Carrington AL, Frost GS, Boulton AJ. Neurovascular disease, antioxidants and glycation in diabetes. Diabetes Metab Res Rev 2002;18:260-72
20. Seidegard J, Vorachek WR, Pero RW, Pearson WR. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 1988;85:7293-7
21. Gronau S, Koenig-Greger D, Jerg M, Riechelmann H. GSTM1 enzyme polymorphism and enzyme activity in correlation to the genotype of detoxification enzymes in squamous cell carcinoma of the oral cavity. Oral Dis 2003;9:62-7